Black Diamond Therapeutics(BDTX) - 2022 Q4 - Annual Report

• our estimates regarding the market opportunities for our product candidates, including our competitive position and the success of competing therapies that are or may become available; • our need for and ability to attract and retain key scientific, management and other personnel and to identify, hire and retain additional qualified professionals; Table of Contents PART I Approved targeted therapies, such as kinase inhibitors, have transformed the treatment of cancers and demonstrated a significant benefi ...